← back to search

Jana M. Ellegast

Massachusetts Institute of Technology · US
🔎 Find collaborators in Hematology · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hematology · Immunology
Research interest
Research interests include Biology, Cancer research, Myeloid leukemia, Leukemia, Peripheral blood, and Cytokine.
h-index
citations
507
works
12
NIH funding
primary concept
email

Recent publications

The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
Nature Cell Biology 2023cited by 43position: middledoi
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Blood 2023cited by 41position: middledoi
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor
Science Translational Medicine 2021cited by 55position: middledoi
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia
Cancer Discovery 2019cited by 40position: middledoi
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
Leukemia 2018cited by 66position: middledoi
Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice
Blood 2016cited by 84position: middledoi
inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice
Blood 2016cited by 47position: firstdoi
MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia
Blood 2016cited by 45position: middledoi
The RET Receptor Tyrosine Kinase Promotes Acute Myeloid Leukemia through Protection of FLT3-ITD Mutants from Autophagic Degradation
Blood 2016cited by 5position: middledoi
ΜΙSΤRG Mice Support Good-Risk AML Engraftment
Blood 2014cited by 3position: firstdoi
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
The Journal of Experimental Medicine 2012cited by 78position: middledoi
Abstract 2773: HSP90 inhibitors target KRAS mutant human tumors through degradation of STK33
Cancer Research 2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stefan Fröhling · German Cancer Research Center4 papers (2012–2018)Markus G. Manz · Supercomputing Systems (Switzerland)4 papers (2014–2016)Claudia Scholl · German Cancer Research Center4 papers (2012–2018) · 3 papers (2014–2016)Kimberly Stegmaier · Harvard University3 papers (2019–2023)Richard A. Flavell · University of California, San Francisco3 papers (2014–2016)Christopher M. Hoffmann · German Cancer Research Center2 papers (2012–2012) · 2 papers (2012–2012)Philipp J. Rauch · Novartis (Switzerland)2 papers (2016–2016)Hartmut Döhner · Medizinische Hochschule Hannover2 papers (2012–2012)Anahita Rafiei · University Hospital Frankfurt2 papers (2016–2016)Anja Pfaus · Universität Ulm2 papers (2016–2018)Mark Schrader · Medizinische Hochschule Hannover2 papers (2012–2012) · 2 papers (2012–2012)Katrin Faber · Credit Suisse (Switzerland)2 papers (2012–2012) · 2 papers (2016–2016)Hans A. Kestler · Johannes Gutenberg University Mainz2 papers (2012–2012) · 2 papers (2016–2018) · 2 papers (2012–2012)Saskia Rudat · University Children's Hospital Tübingen2 papers (2016–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hematology · Immunology →